Suppr超能文献

皮肤角质形成细胞衍生的SIRT1和脑源性神经营养因子调节糖尿病性神经病变小鼠模型中的机械性异常性疼痛。

Skin keratinocyte-derived SIRT1 and BDNF modulate mechanical allodynia in mouse models of diabetic neuropathy.

作者信息

O'Brien Jennifer, Niehaus Peter, Chang Koping, Remark Juliana, Barrett Joy, Dasgupta Abhishikta, Adenegan Morayo, Salimian Mohammad, Kevas Yanni, Chandrasekaran Krish, Kristian Tibor, Chellappan Rajeshwari, Rubin Samuel, Kiemen Ashley, Lu Catherine Pei-Ju, Russell James W, Ho Cheng-Ying

机构信息

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.

Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.

出版信息

Brain. 2024 Oct 3;147(10):3471-3486. doi: 10.1093/brain/awae100.

Abstract

Diabetic neuropathy is a debilitating disorder characterized by spontaneous and mechanical allodynia. The role of skin mechanoreceptors in the development of mechanical allodynia is unclear. We discovered that mice with diabetic neuropathy had decreased sirtuin 1 (SIRT1) deacetylase activity in foot skin, leading to reduced expression of brain-derived neurotrophic factor (BDNF) and subsequent loss of innervation in Meissner corpuscles, a mechanoreceptor expressing the BDNF receptor TrkB. When SIRT1 was depleted from skin, the mechanical allodynia worsened in diabetic neuropathy mice, likely due to retrograde degeneration of the Meissner-corpuscle innervating Aβ axons and aberrant formation of Meissner corpuscles which may have increased the mechanosensitivity. The same phenomenon was also noted in skin-keratinocyte specific BDNF knockout mice. Furthermore, overexpression of SIRT1 in skin induced Meissner corpuscle reinnervation and regeneration, resulting in significant improvement of diabetic mechanical allodynia. Overall, the findings suggested that skin-derived SIRT1 and BDNF function in the same pathway in skin sensory apparatus regeneration and highlighted the potential of developing topical SIRT1-activating compounds as a novel treatment for diabetic mechanical allodynia.

摘要

糖尿病性神经病变是一种以自发性和机械性异常性疼痛为特征的使人衰弱的疾病。皮肤机械感受器在机械性异常性疼痛发展过程中的作用尚不清楚。我们发现,患有糖尿病性神经病变的小鼠足部皮肤中的沉默调节蛋白1(SIRT1)脱乙酰酶活性降低,导致脑源性神经营养因子(BDNF)表达减少,随后表达BDNF受体TrkB的机械感受器——迈斯纳小体的神经支配丧失。当皮肤中的SIRT1被耗尽时,糖尿病性神经病变小鼠的机械性异常性疼痛加剧,这可能是由于支配迈斯纳小体的Aβ轴突逆行变性以及迈斯纳小体异常形成,这可能增加了机械敏感性。在皮肤角质形成细胞特异性BDNF基因敲除小鼠中也观察到了同样的现象。此外,皮肤中SIRT1的过表达诱导了迈斯纳小体的神经再支配和再生,从而显著改善了糖尿病性机械性异常性疼痛。总体而言,这些发现表明,皮肤来源的SIRT1和BDNF在皮肤感觉器官再生的同一途径中发挥作用,并突出了开发局部SIRT1激活化合物作为糖尿病性机械性异常性疼痛新疗法的潜力。

相似文献

本文引用的文献

10
Diabetic neuropathy.糖尿病性神经病。
Nat Rev Dis Primers. 2019 Jun 13;5(1):41. doi: 10.1038/s41572-019-0092-1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验